D-1043-2014 Class III Terminated
FDA drug recall D-1043-2014 was initiated by Actavis Inc on Nov 15, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months. The recall status is terminated (terminated Jun 16, 2015). Affected quantity: 139,944 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 5, 2014
- Initiation Date
- Nov 15, 2013
- Termination Date
- Jun 16, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 139,944 bottles
Product description
BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880
Reason for recall
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lots: 524099M, 524100A, 521687A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1043-2014
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026